tyrosyl-isoleucyl-glycyl-seryl-arginine has been researched along with transforming growth factor beta in 1 studies
Studies (tyrosyl-isoleucyl-glycyl-seryl-arginine) | Trials (tyrosyl-isoleucyl-glycyl-seryl-arginine) | Recent Studies (post-2010) (tyrosyl-isoleucyl-glycyl-seryl-arginine) | Studies (transforming growth factor beta) | Trials (transforming growth factor beta) | Recent Studies (post-2010) (transforming growth factor beta) |
---|---|---|---|---|---|
111 | 0 | 29 | 49,119 | 560 | 17,610 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kim, WH; Kleinman, HK; Nomizu, M; Schnaper, HW; Yamada, Y | 1 |
1 other study(ies) available for tyrosyl-isoleucyl-glycyl-seryl-arginine and transforming growth factor beta
Article | Year |
---|---|
Apoptosis in human fibrosarcoma cells is induced by a multimeric synthetic Tyr-Ile-Gly-Ser-Arg (YIGSR)-containing polypeptide from laminin.
Topics: Amino Acid Sequence; Apoptosis; Cell Adhesion; Cell Division; Fibrosarcoma; Humans; Laminin; Molecular Sequence Data; Oligopeptides; RNA, Messenger; Transforming Growth Factor beta; Tumor Cells, Cultured | 1994 |